Article Details

Syros Pharmaceuticals (NASDAQ:SYRS) Lifted to "Buy" at Zacks Investment Research

Retrieved on: 2021-02-02 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Syros Pharmaceuticals (NASDAQ:SYRS) Lifted to "Buy" at Zacks Investment Research. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 46,331 shares of the company's stock worth $410,000 after purchasing an additional 7,203 shares in the last ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up